EGFR L747P mutation in one lung adenocarcinoma patient responded to afatinib treatment: a case report.

Zhou, Tong; Zhou, Xiaoyue; Li, Peng; Qi, Chuang; Ling, Yang

Zhou, Tong; Zhou, Xiaoyue; Li, Peng; Qi, Chuang; Ling, Yang.

Afiliação

Zhou T; Department of Medical Oncology, Changzhou Cancer Hospital of Soochow University, Changzhou 213032, China.
Zhou X; Department of Medical Oncology, Changzhou Cancer Hospital of Soochow University, Changzhou 213032, China.
Li P; Department of Medical Oncology, Changzhou Cancer Hospital of Soochow University, Changzhou 213032, China.
Qi C; The Medical Department, 3D Medicines Inc., Shanghai 201100, China.
Ling Y; Department of Medical Oncology, Changzhou Cancer Hospital of Soochow University, Changzhou 213032, China.

J Thorac Dis ; 10(12): E802-E805, 2018 Dec.

Article em En | MEDLINE | ID: mdl-30746257

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Thorac Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google